A. Al-Abdulaali

Safety and efficacy of short cetuximab infusion for patients with metastatic colorectal cancer

BackgroundCetuximab is an FDA approved anti-EGFR monoclonal antibody that is given to patients with metastatic colorectal cancer (mCRC) who are KRAS and NRAS wildtype (wt). Dosing of cetu...

K. Alshammari ;

F. Alotaibi ;

H. Shehata ;

M. Alkaiyat ;

J. Al Qahtani ;

A. Alolayan ;

M. Algarni ;

Mohamed M. Ali ;

A. Abushara ;

A. Al-Abdulaali ;

06/25/2023

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

A. Al-Abdulaali

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products